Home › Obstructive Sleep Apnea › NCT05382754

Home Apnea Testing in CHildren Trial

Home Sleep Apnea Testing Compared to In-lab Polysomnography for the Evaluation of Obstructive Sleep Apnea in Children

Who can join

Ages 5 to 12 · All sexes

Inclusion Criteria:

* Male and female children age 5-12 years old inclusive
* Referred for diagnostic PSG at the Children's Hospital of Philadelphia (CHOP) Sleep Laboratory for evaluation of OSA as part of clinical care
* Parental/guardian permission (informed consent) and if appropriate, child assent.

Exclusion Criteria:

* Children without Down syndrome who have had a PSG within 3 years of enrollment
* Children with Down syndrome who have had a PSG within 1 year of enrollment.
* Children with a history of hypoventilation or hypoxemia or who require supplemental oxygen or positive airway pressure during sleep
* Children with a tracheostomy or tracheocutaneous fistula
* Children who live in a facility without their parent

About the study

This clinical trial will compare home sleep apnea testing with the gold standard in-lab polysomnography in terms of 1) accuracy, 2) therapeutic decision-making, and 3) parent/child acceptability in children referred for evaluation of obstructive sleep apnea.

What is being tested

• Home sleep apnea test (diagnostic test)
• In-lab polysomnography (diagnostic test)

Sponsor: Children's Hospital of Philadelphia · Participants: 317 · Started: Mar 29, 2023

Contact the study team

• Christopher M Cielo, DO · Phone: 2674265748
• Ignacio E Tapia, MD · Phone: 305-243-9885

Official record on ClinicalTrials.gov — NCT05382754

Locations in the U.S.

Conditions

• Obstructive Sleep Apnea
• Sleep Disorders
• Sleep Apnea
• Parasomnias

From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.